1. Home
  2. EVO vs ASA Comparison

EVO vs ASA Comparison

Compare EVO & ASA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.50

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

ASA

ASA Gold and Precious Metals Limited

HOLD

Current Price

$73.49

Market Cap

1.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVO
ASA
Founded
1993
1958
Country
Germany
United States
Employees
4766
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
N/A
2003

Fundamental Metrics

Financial Performance
Metric
EVO
ASA
Price
$3.50
$73.49
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
138.6K
165.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
0.09%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$7.13
N/A
P/E Ratio
N/A
$1.96
Revenue Growth
N/A
N/A
52 Week Low
$2.84
$23.93
52 Week High
$4.80
$78.21

Technical Indicators

Market Signals
Indicator
EVO
ASA
Relative Strength Index (RSI) 49.94 57.11
Support Level $3.52 $65.80
Resistance Level $3.67 $73.60
Average True Range (ATR) 0.09 3.19
MACD -0.02 -0.15
Stochastic Oscillator 36.36 86.14

Price Performance

Historical Comparison
EVO
ASA

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About ASA ASA Gold and Precious Metals Limited

ASA Gold And Precious Metals Ltd is a closed-end, non-diversified investment company. Its objective is to provide long-term capital appreciation through investing in companies engaged in the exploration for, development of projects, or mining of precious metals and minerals.

Share on Social Networks: